BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10211998)

  • 1. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas.
    Machado JC; Soares P; Carneiro F; Rocha A; Beck S; Blin N; Berx G; Sobrinho-Simões M
    Lab Invest; 1999 Apr; 79(4):459-65. PubMed ID: 10211998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
    Ascaño JJ; Frierson H; Moskaluk CA; Harper JC; Roviello F; Jackson CE; El-Rifai W; Vindigni C; Tosi P; Powell SM
    Mod Pathol; 2001 Oct; 14(10):942-9. PubMed ID: 11598162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma.
    Machado JC; Oliveira C; Carvalho R; Soares P; Berx G; Caldas C; Seruca R; Carneiro F; Sobrinho-Simöes M
    Oncogene; 2001 Mar; 20(12):1525-8. PubMed ID: 11313896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The common 18-base pair deletion at codons 418-423 of the E-cadherin gene in differentiated-type adenocarcinomas and intramucosal precancerous lesions of the stomach with the features of gastric foveolar epithelium.
    Endoh Y; Tamura G; Watanabe H; Ajioka Y; Motoyama T
    J Pathol; 1999 Oct; 189(2):201-6. PubMed ID: 10547575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational analysis of the CASP6 gene in colorectal and gastric carcinomas.
    Lee JW; Kim MR; Soung YH; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
    APMIS; 2006 Sep; 114(9):646-50. PubMed ID: 16948818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the human E-cadherin (CDH1) gene.
    Berx G; Becker KF; Höfler H; van Roy F
    Hum Mutat; 1998; 12(4):226-37. PubMed ID: 9744472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of eleven novel tumor-associated E-cadherin mutations. Mutations in brief no. 215. Online.
    Becker KF; Reich U; Schott C; Becker I; Berx G; van Roy F; Höfler H
    Hum Mutat; 1999; 13(2):171. PubMed ID: 10094558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of the E-cadherin gene in human gynecologic cancers.
    Risinger JI; Berchuck A; Kohler MF; Boyd J
    Nat Genet; 1994 May; 7(1):98-102. PubMed ID: 8075649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline mutations of E-cadherin gene in Korean familial gastric cancer patients.
    Yoon KA; Ku JL; Yang HK; Kim WH; Park SY; Park JG
    J Hum Genet; 1999; 44(3):177-80. PubMed ID: 10319582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility.
    Handschuh G; Candidus S; Luber B; Reich U; Schott C; Oswald S; Becke H; Hutzler P; Birchmeier W; Höfler H; Becker KF
    Oncogene; 1999 Jul; 18(30):4301-12. PubMed ID: 10439038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence for mutations in the alpha- and beta-catenin genes in human gastric and breast carcinomas.
    Candidus S; Bischoff P; Becker KF; Höfler H
    Cancer Res; 1996 Jan; 56(1):49-52. PubMed ID: 8548773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus.
    Wijnhoven BP; de Both NJ; van Dekken H; Tilanus HW; Dinjens WN
    Br J Cancer; 1999 Jul; 80(10):1652-7. PubMed ID: 10408414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of the p16/MTS1-tumor suppressor gene in gastric cancer.
    Günther T; Schneider-Stock R; Pross M; Manger T; Malfertheiner P; Lippert H; Roessner A
    Pathol Res Pract; 1998; 194(12):809-13. PubMed ID: 9894245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diffuse stomach carcinoma: from H&E diagnosis and molecular pathology to specific therapy].
    Höfler H
    Verh Dtsch Ges Pathol; 1999; 83():148-54. PubMed ID: 10714205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of ras oncogene in gastric adenocarcinoma: association with histological phenotype.
    Kim TY; Bang YJ; Kim WS; Kang SH; Lee KU; Choe KJ; Kim NK
    Anticancer Res; 1997; 17(2B):1335-9. PubMed ID: 9137494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An efficient and reliable multiplex PCR-SSCP mutation analysis test applied to the human E-cadherin gene.
    Berx G; Nollet F; Strumane K; van Roy F
    Hum Mutat; 1997; 9(6):567-74. PubMed ID: 9195232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse growth pattern affects E-cadherin expression in invasive breast cancer.
    Brinck U; Jacobs S; Neuss M; Tory K; Rath W; Kulle B; Füzesi L
    Anticancer Res; 2004; 24(4):2237-42. PubMed ID: 15330167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer.
    Huiping C; Sigurgeirsdottir JR; Jonasson JG; Eiriksdottir G; Johannsdottir JT; Egilsson V; Ingvarsson S
    Br J Cancer; 1999 Dec; 81(7):1103-10. PubMed ID: 10584868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of p53 gene in gastric carcinoma in Taiwan.
    Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
    Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.